Goldman Sachs Reinstates CVS Health (CVS) at Neutral

Goldman Sachs analyst Robert Jones reinstates coverage on CVS Health (NYSE: CVS) with a Neutral rating and a price target of $87.00.

The analyst says NT synergies appear attainable but comes out on the sidelines noting large questions loom on the success of the integration model.

For an analyst ratings summary and ratings history on CVS Health click here. For more ratings news on CVS Health click here.

Shares of CVS Health closed at $80.27 yesterday.

You May Also Be Interested In

• Piper Sandler Starts Kura Sushi USA Inc. (KRUS) at Neutral, 'Risk Reward as relatively balanced'
• Kimberly Clark (KMB) PT Raised to $160 at Evercore ISI
• American Express (AXP) PT Raised to $255 at Evercore ISI